ScreenerHero

CMNDClearmind Medicine Inc. Common Shares

NAS · US · Healthcare · Biotechnology · clearmindmedicine.com
1.740USDMkt Cap: 2.58M $P/E: —

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.58M $
Enterprise Value-10.92M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.86M $
Revenue/Share—
Last Price1.740 USD
Fiscal Year EndOct 2025
MR QuarterApr 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA1.35
EV/Revenue—
P/S—
P/B0.15
EPS (TTM)-175.92
EPS (Forward)—
52W Range
1.7400% of range1.804
52W High1.804 USD
52W Low1.740 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-323.41%
ROA-63.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.73M $
CapEx (TTM)—
FCF Margin—
FCF Yield-136.48%
Net Debt-13.51M $
Net Debt/EBITDA1.67
Balance Sheet
Debt/Equity1.49
Current Ratio4.79
Quick Ratio4.73
Book Value/Sh11.28 USD
Cash/Share9.150 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.49M
Float1.48M
Insiders0.09%
Institutions3.30%
Short Interest
Short Ratio0.1d
Short % Float3.23%
Short % Out.3.23%
Shares Short47.94K
Short (prev mo.)203.36K
Technical
SMA 502.099 (-17.1%)
SMA 20024.19 (-92.8%)
Beta-1.18
S&P 52W Chg19.18%
Avg Vol (30d)45.77K
Avg Vol (10d)150.19K
Technical Indicators
RSI (14)43.7
MACD-0.0754
MACD Signal-0.1296
MACD Hist.+0.0542
BB Upper1.983 USD
BB Middle1.706 USD
BB Lower1.430 USD
BB Width32.37%
ATR (14)0.1715 USD
Vol Ratio (20d)0.31x